Redouane-Salah Azzedine, Souad Ameddah, Kerkatou Wafa, Wojnicki Kamil, Ramos Adrian M, Ortiz Alberto, Kaminska Bozena, Menad Ahmed
Laboratoire de Biologie et Environnement, Faculté des Sciences de la Nature et de la Vie, Université Frères Mentouri Constantine 1, Route Aïn El Bey, 25000, Constantine, Algérie.
Unité de Recherche, Valorisation des Ressources Naturelles, Molécules Bioactives et Analyses Physicochimiques et Biologiques (VARENBIOMOL), Université Frères Mentouri, Constantine 1, Route Aïn El Bey, 25 000 Constantine, Algérie.
Iran J Basic Med Sci. 2024;27(8):1023-1032. doi: 10.22038/IJBMS.2024.77052.16661.
The present study aimed to explore the mechanisms underlying the potency of the renoprotective effect of the EtOAc fraction of (EALD) (Plumbaginaceae) against cyclosporine A (CsA), in comparison to vitamin E (Vit. E).
In the experiment, a model of CsA-induced nephrotoxicity was established by dosing male Wistar rats with 25 mg/kg, for 14 days. The protective effect of EALD was investigated through pretreatment of rats with a dose of 200 mg/kg for 14 days, compared to the oral administration of Vit. E at 100 mg/kg. Renal function and markers of oxidative stress were then assessed. Furthermore, a complementary study was carried out to evaluate CsA-induced endoplasmic reticulum stress (ERS) and inflammation on cell culture (3T3 cells and MCT cells) using western blot and quantitative RT-PCR..
Pretreatment of rats with EALD significantly attenuated the elevated levels of renal dysfunction markers (BUN, creatinine) and suppressed malondialdehyde (MDA) levels; It also significantly regulated the changes in superoxide dismutase (SOD), reduced glutathione (GSH), glutathione peroxydase (GPx), and glutathione S-transferase (GST) levels as compared to Vit. E, demonstrating a more effective recovery in renal tissues. Treatment of cells with CsA was linked to the expression of ERS and inflammatory markers activating transcription factor (ATF4), inositol-requiring enzyme 1α (IRE1α), binding immunoglobulin protein (BiP), and monocyte chemoattractant protein-1 (MCP1). In contrast, pretreatment of cells with EALD resulted in a significant decrease in both ERS and inflammatory markers.
These findings indicate the renoprotective potential of , as it demonstrated the ability to ameliorate CsA-induced renal dysfunction through its distinctive antioxidant properties.
本研究旨在探讨与维生素E(Vit.E)相比,白花丹(EALD)(白花丹科)乙酸乙酯部位对环孢素A(CsA)肾脏保护作用的潜在机制。
在实验中,通过给雄性Wistar大鼠腹腔注射25mg/kg CsA,持续14天,建立CsA诱导的肾毒性模型。与口服100mg/kg Vit.E相比,研究了EALD以200mg/kg剂量预处理大鼠14天的保护作用。然后评估肾功能和氧化应激标志物。此外,还进行了一项补充性细胞培养研究,使用蛋白质免疫印迹法和定量逆转录聚合酶链反应评估CsA诱导的内质网应激(ERS)和炎症(3T3细胞和MCT细胞)。
用EALD预处理大鼠可显著降低肾功能障碍标志物(尿素氮、肌酐)的升高水平,并抑制丙二醛(MDA)水平;与Vit.E相比,它还显著调节了超氧化物歧化酶(SOD)、还原型谷胱甘肽(GSH)、谷胱甘肽过氧化物酶(GPx)和谷胱甘肽S-转移酶(GST)水平的变化,表明肾组织有更有效的恢复。用CsA处理细胞与ERS和炎症标志物激活转录因子(ATF4)、肌醇需求酶1α(IRE1α)、结合免疫球蛋白蛋白(BiP)和单核细胞趋化蛋白-1(MCP1)的表达有关。相比之下,用EALD预处理细胞可导致ERS和炎症标志物显著降低。
这些发现表明白花丹具有肾脏保护潜力,因为它通过其独特的抗氧化特性表现出改善CsA诱导的肾功能障碍的能力。